Howard Schiller, interim chief executive of Valeant Pharmaceuticals International Inc., is expected to urge House lawmakers Thursday to rewrite rules that make it illegal for drug companies to help Medicare patients pay the out-of-pocket costs of their prescriptions.
Such assistance for patients in Medicare and other government-funded health-care programs is considered an illegal kickback under federal law, so drug companies limit offering the help only to patients who are commercially insured.
Read Full Article »